Autopsy report · NCT03981757

Study of Regional Cerebral Oxygenation and Brain Blood Volume Changes During Carotid Endarterectomy Using the NeurOS System

“sponsor withdrew”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

University of Louisville

Sponsor type

University, hospital or other

Conditions

Carotid Disease

Interventions

NeurOS

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• An Exploratory Investigation to Assess Changes in Quality of Life for Individuals With Type 2 Diabetes After Taking a Meal-replacement Shake.
  “Sponsor withdrawn” (96% match in meaning)
• Mirabegron for the Treatment of Pain Motivated Urinary Frequency and Urgency in Women
  “Withdrawn by Sponsor” (94% match in meaning)
• Dose Escalation Study of Nelfinavir Plus MLN9708 in Patients With Advanced Solid Tumors or Lymphoma
  “Sponsor withdrew support” (93% match in meaning)
• Quetiapine XR for Cognitive and Functional Disability in Clinically Stable Patients With Bipolar Disorder
  “Sponsor withdrew funding” (90% match in meaning)
• Technology-Based Application To Improve The Triple Therapy Adherence Rate In Subjects With Hepatitis C Infection
  “Sponsored withdrew” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.